Feed/Investors/American Cancer Society BrightEdge

American Cancer Society BrightEdge

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-05-06

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$220M

across 1 round

LATEST ROUND

Series D · $220M · 2026-05-06

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
CellCentric A drug-discovery platform	Series D Verified against 4 of 7 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts.	$220M	2026-05-06	[ PART ]